US 9662312
Method for treating glomerulosclerosis
granted A61KA61K31/422A61K9/2013
Quick answer
US patent 9662312 (Method for treating glomerulosclerosis) held by Ligand Pharmaceuticals Incorporated expires Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ligand Pharmaceuticals Incorporated
- Grant date
- Tue May 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/422, A61K9/2013, A61K9/2018, A61K9/2031